Form D · Private Equity Fund
Oaktree Life Sciences Income Fund (Parallel), L.P.
Los Angeles, CA · CIK 0002048690
Offering snapshot reported Jan 29, 2025 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 29, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06c, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-536747
OCM Investments, LLC, CRD #128803, and Brookfield Oaktree Wealth Solutions LLC, CRD #313390, will place the investments but are not anticipated to receive sales commissions.
Source: Form D, filed Jan 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Frank | Executive |
| Bruce Karsh | Executive |
| Daniel Levin | Executive |
| Howard Marks | Executive |
| Todd Molz | Executive |
| N/A Oaktree Capital Management, L.P. | Promoter |
| N/A Oaktree Life Sciences Income Fund Gp, L.P. | Executive |
| Robert O'leary | Executive |
| Armen Panossian | Executive |
| Sheldon Stone | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
333 S. Grand Avenue, 28 Th Floor
Los Angeles, CA, 90071
Los Angeles, CA, 90071